X-72273943-A-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000316084.10(RPS4X):āc.390T>Gā(p.Phe130Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000538 in 1,209,105 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000316084.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS4X | NM_001007.5 | c.390T>G | p.Phe130Leu | missense_variant | 5/7 | ENST00000316084.10 | NP_000998.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS4X | ENST00000316084.10 | c.390T>G | p.Phe130Leu | missense_variant | 5/7 | 1 | NM_001007.5 | ENSP00000362744 | P1 | |
RPS4X | ENST00000486733.2 | n.1460T>G | non_coding_transcript_exon_variant | 3/5 | 5 | |||||
PIN4 | ENST00000439980.7 | c.238-25039A>C | intron_variant, NMD_transcript_variant | 4 | ENSP00000394066 |
Frequencies
GnomAD3 genomes AF: 0.0000448 AC: 5AN: 111588Hom.: 0 Cov.: 22 AF XY: 0.0000592 AC XY: 2AN XY: 33764
GnomAD3 exomes AF: 0.0000165 AC: 3AN: 182261Hom.: 0 AF XY: 0.0000300 AC XY: 2AN XY: 66753
GnomAD4 exome AF: 0.0000547 AC: 60AN: 1097517Hom.: 0 Cov.: 30 AF XY: 0.0000579 AC XY: 21AN XY: 362887
GnomAD4 genome AF: 0.0000448 AC: 5AN: 111588Hom.: 0 Cov.: 22 AF XY: 0.0000592 AC XY: 2AN XY: 33764
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.390T>G (p.F130L) alteration is located in exon 5 (coding exon 5) of the RPS4X gene. This alteration results from a T to G substitution at nucleotide position 390, causing the phenylalanine (F) at amino acid position 130 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at